Comparison of the effect of sodium valproate, levetiracetam, and lamotrigine on seizure attacks and EEG disorders in patients with juvenile myoclonic epilepsy
Not Applicable
- Conditions
- juvenile myoclonic epilepsy.Generalized idiopathic epilepsy and epileptic syndromes
- Registration Number
- IRCT201509079014N79
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 105
Inclusion Criteria
affected with juvenile myoclonic epilepsy; age of over 12 years.
Exclusion criteria: having severe organic diseases, heart failure, liver disorder, renal disease, or electrolyte disorder; abnormal MRI image; mental retardation; pregnancy or breastfeeding; alcohol or drug dependence; needing to more than one drug for controlling seizure; noncompliance.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing seizure attacks. Timepoint: before intervention, and 1, 2, and 6 months after intervention. Method of measurement: through history taking.
- Secondary Outcome Measures
Name Time Method Assessing EEG disorders. Timepoint: before intervention, and 1, 2, and 6 months after intervention. Method of measurement: using electroencephalogram.